77.95 USD
↘ 2.33 (2.90%)LIVE (AS OF 02:00 PM EST)
Tarsus Pharmaceuticals, Inc. Common Stock (TARS) trades at $77.95 per share. There is a divergence between signals — technical indicators rate "Strong Buy" but underlying fundamentals lean "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Nov 13, 2026.